23.65

1.20% 0.29

Evolent Health Inc (EVH)

Overview News Price History Option Chain Financials Why EVH Down? Discussions Forecast

Evolent Health Inc stock is traded at $23.65, with a volume of 333.93K. It is up +1.20% in the last 24 hours and down -10.25% over the past month. Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

Previous Close:

$23.36

Open:

$23.13

24h Volume:

333.93K

Relative Volume:

0.16

Market Cap:

$2.72B

Revenue:

$2.35B

Net Income/Loss:

$-74.42M

P/E Ratio:

-23.19

EPS:

-1.02

Net Cash Flow:

$150.93M

1W Performance:

+1.59%

1M Performance:

-10.25%

6M Performance:

-12.77%

1Y Performance:

-13.28%

1-Day Range:

$23.13

$23.70

1-Week Range:

$22.90

$24.57

52-Week Range:

$17.98

$35.00

Evolent Health Inc Stock (EVH) Company Profile

Name

Evolent Health Inc

Sector

Healthcare (1181)

Industry

Health Information Services (61)

Phone

571-389-6000

Address

800 NORTH GLEBE RD, SUITE 500, ARLINGTON

Employee

4,700

Twitter

@EvolentHealth

Next Earnings Date

2024-11-07

Latest SEC Filings

EVH's Discussions on Twitter

Evolent Health Inc Stock (EVH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-11-24	Initiated	KeyBanc Capital Markets	Overweight
Aug-09-24	Upgrade	Truist	Hold → Buy
Apr-22-24	Initiated	Citigroup	Buy
Mar-01-24	Initiated	Oppenheimer	Outperform
Jan-03-24	Initiated	Barclays	Overweight
Dec-06-23	Initiated	JMP Securities	Mkt Outperform
Oct-16-23	Initiated	UBS	Buy
Apr-12-23	Initiated	Stephens	Overweight
Nov-01-22	Initiated	Truist	Hold
Jul-29-22	Initiated	RBC Capital Mkts	Outperform
Mar-30-22	Initiated	Guggenheim	Buy
Nov-18-21	Upgrade	JP Morgan	Neutral → Overweight
Apr-29-21	Resumed	JP Morgan	Neutral
Jan-07-21	Initiated	BTIG Research	Buy
Jul-06-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jun-05-20	Downgrade	Goldman	Buy → Neutral
Jun-02-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Oct-05-18	Resumed	Leerink Partners	Outperform
Jun-04-18	Initiated	Piper Jaffray	Overweight
Apr-24-18	Resumed	JP Morgan	Neutral
Sep-20-17	Initiated	KeyBanc Capital Mkts	Overweight
Jun-02-17	Initiated	Robert W. Baird	Outperform
Mar-14-17	Initiated	Oppenheimer	Outperform
Jan-13-17	Upgrade	Wells Fargo	Market Perform → Outperform
Oct-28-16	Resumed	JP Morgan	Overweight
Aug-05-16	Reiterated	FBR Capital	Outperform
Jul-26-16	Initiated	Jefferies	Buy
Jul-13-16	Reiterated	FBR Capital	Outperform
Mar-29-16	Initiated	FBR Capital	Outperform
Jan-06-16	Initiated	Canaccord Genuity	Buy
Jun-30-15	Initiated	Goldman	Buy
Jun-30-15	Initiated	JP Morgan	Overweight
Jun-30-15	Initiated	Leerink Partners	Outperform
Jun-30-15	Initiated	Sun Trust Rbsn Humphrey	Buy

View All

Evolent Health Inc Stock (EVH) Latest News

Nov 04, 2024